Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2-3
|
pubmed:dateCreated |
1992-6-26
|
pubmed:abstractText |
Clinical findings, treatment and results have been recorded prospectively in 661 patients with carcinoma of the head and neck. With an average follow-up of 3 years 7813 follow-up consultations revealed 220 recurrences. The overall "recurrence pick-up rate" and subsequent "cure rate" was 1:36 and 1:113 consultations, respectively. Laryngeal carcinomas treated with radiotherapy and oral carcinomas receiving radiotherapy and limited resections showed recurrence "cure-rates" of 1:89 and 1:110, respectively. For other tumour sites the average "cure-rate" was 1:238. Only 39% of the recurrences were detected through physical examination. Follow-up consultations revealed 9.1% of second primaries. More time should be spent on training patients to recognise symptoms and signs of recurrence. Routine follow-up is rarely indicated beyond the third year after completion of treatment, or in patients for whom we have little to offer in terms of curative treatment.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0959-8049
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
426-30
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1591057-Adult,
pubmed-meshheading:1591057-Aged,
pubmed-meshheading:1591057-Aged, 80 and over,
pubmed-meshheading:1591057-Carcinoma, Squamous Cell,
pubmed-meshheading:1591057-Female,
pubmed-meshheading:1591057-Follow-Up Studies,
pubmed-meshheading:1591057-Head and Neck Neoplasms,
pubmed-meshheading:1591057-Humans,
pubmed-meshheading:1591057-Male,
pubmed-meshheading:1591057-Middle Aged,
pubmed-meshheading:1591057-Neoplasm Recurrence, Local,
pubmed-meshheading:1591057-Prospective Studies,
pubmed-meshheading:1591057-Time Factors
|
pubmed:year |
1992
|
pubmed:articleTitle |
The value of follow-up in patients treated for squamous cell carcinoma of the head and neck.
|
pubmed:affiliation |
Department of Otolaryngology, University of Oslo, Norway.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|